Pediatric Cancer Therapeutics Development
This book provides a comprehensive overview of the scientific, medical, regulatory, and economic considerations associated with the discovery, development, and delivery of novel therapeutics for children with cancer. Co-authored by a diverse team from academic, government, and industry backgrounds, the book describes the steps in the process from the identification of a promising therapeutic target to the evaluation of drug candidates in the various phases of clinical testing and regulatory review. Throughout, special emphasis is placed on the unique biology of pediatric malignancies and the medical and social needs of children and their families. In providing a firm grounding in the drug development process, the book will be of value to all with an interest in how medicines currently used to treat pediatric cancer were made available. This includes trainees as well as established practitioners and others participating in translational and clinical research in the academic setting.
181 pages, 3 editions
English edition · First published 2022 by Springer · ISBN 9783031063565
Be the first to rate this book
Editions
3 editions
English
- Pediatric Cancer Therapeutics Development · Springer · 2022 · ISBN 9783031063565 This page
- Pediatric Cancer Therapeutics Development · Springer International Publishing · 2022 · ISBN 9783031063589
- Pediatric Cancer Therapeutics Development · Springer International Publishing · 2022 · ISBN 9783031063572
Keep track of what you read
Book Nook is a free reading tracker with a 3D bookshelf, a reading timer, challenges with friends and a Reading Wrapped at the end of the year. Add Pediatric Cancer Therapeutics Development to your shelf in one tap.